Sonavex, Inc. news
Sonavex, Inc., a privately held medical device company focused on empowered patient care, announced that it received a $3 million Phase IIB Small Business Innovation Research (SBIR) grant from the National Institutes of Health to use its EchoMark & EchoSure devices to support arteriovenous (AV) fistula maturation and long-term viability. The award provides capital for prospective clinical studies and continued research and development efforts.
There are millions of patients worldw
The FDA has granted its seal of approval to Sonavex to begin shipping its EchoSure system to providers across the U.S.
A combination of 3D ultrasound imaging and advanced deep learning algorithms, the device automates visual and quantitative analysis to monitor and provide up-to-date information on blood flow following surgical procedures.
“Doppler ultrasound is an accurate imaging modality that is inexpensive, portable,
Sonavex, Inc., a privately held medical device company focused on empowered patient care, announced today that on March 8, 2019 it received 510(k) clearance from the U.S. Food and Drug Administration for its EchoSureTM device to deliver definitive blood flow data on demand.
The EchoSure system combines 3D ultrasound imaging with advanced deep learning algorithms to automate visual and quantitative blood flow monitoring after surgery. Coupled with Sonavex’s FDA-cleared EchoM
Sonavex, Inc., a privately held medical device company focused on improving surgical patient outcomes with point-of-care imaging technologies, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its EchoMark and EchoMark LP soft tissue markers.
EchoMark and EchoMark LP (Low Profile) are highly echogenic, resorbable polymeric implants used for marking soft tissue sites in surgical patients. EchoMark’s unique ultrasound refl